Companies: 10,795·Total market cap: $144.5T
RespireRx Pharmaceuticals Inc.

RespireRx Pharmaceuticals Inc.

RSPIOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$657754
P/E Ratio
52W High$0.0027
52W Low$0.0001
Overview

RespireRx Pharmaceuticals Inc. (RSPI) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · RSPI · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-0.01rspi eps ttm · rspi earnings per shareEarnings history
PE Ratio (TTM)rspi pe ratio ttm · rspi price to earningsPE Ratio deep dive
Revenue (TTM)0.00rspi revenue ttm · rspi annual revenueFull revenue history
Dividend YieldNo Dividenddoes rspi pay dividends · rspi dividend yieldDividend history
Shares Outstanding111.3Mrspi shares outstanding · rspi floatShares outstanding history
Next EarningsTBArspi earnings date · rspi next earningsEarnings history

Financial Snapshot

Full Financials
FY 2022Revenue$0.00
202020212022
respirerx pharmaceuticals inc. revenue · rspi revenue 2022
FY 2022Net Income-$2.1M▲ +45.66% YoY
202020212022
respirerx pharmaceuticals inc. net income · rspi profit 2022
FY 2022EPS$-0.04▲ +10.53% YoY
202020212022
rspi eps · respirerx pharmaceuticals inc. earnings per share 2022
TTM:Revenue: $0.00Net Income: -$1.8MEPS: $-0.01View income statement →

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+63.64%
YTD+0.00%
1Y+157.14%
5Y-93.08%

About RespireRx Pharmaceuticals Inc.

CEOArnold S. Lippa
IPO DateNov 6, 1989
Employees2
CountryUS

RespireRx Pharmaceuticals Inc. is dedicated to researching, developing, and commercializing pharmaceutical products aimed at addressing neurological and psychiatric conditions. The company operates th…

what is respirerx pharmaceuticals inc. · rspi stock overview · respirerx pharmaceuticals inc. company profile · who is respirerx pharmaceuticals inc. ceo · rspi OTC · respirerx pharmaceuticals inc. headquarters · respirerx pharmaceuticals inc. business segments

About Stock Overview & Key Data

RespireRx Pharmaceuticals Inc. (RSPI) is a Healthcare company in the Biotechnology industry, listed on OTC since Nov 6, 1989. As of the latest trading session, RSPI stock price is $0.00, with a market capitalization of $657,754. The stock has returned +157.14% over the past 12 months and +0.00% year-to-date.

In fiscal year 2022, RespireRx Pharmaceuticals Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, RespireRx Pharmaceuticals Inc. (RSPI) stock price is $0.00. The stock is traded on OTC under the ticker symbol RSPI. The 52-week range is $0.00 – $0.00.

RSPI stock priceRSPI quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice